Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
MDA
Amanita muscaria
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
25I-NBOH
Tree.jpgJapanese Garden by Anonymous
1P-LSD
Experience:25mg 3-MeO-PCP - Enhanced film experience
2C-B-FLY
4-HO-MiPT
LSM-775
Escaline
Experience:300µg LSD - Togetherness and the Silent Dusk
3C-E
2C-I
Experience:250mg DXM - DXM Itch and Trip Report
LSA
25D-NBOMe
Bromo-DragonFLY
Enhancement of colour rose.jpgRose by Chelsea Morgan
2C-E
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
Phenethylamine (compound)
3-MMC
ΑMT
4-HO-DPT
Experience:3-MeO-PCP - Extreme psychosis
Psilocin
4-HO-DET
Pramiracetam
Efavirenz
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
JWH-018
DPT
MDMA
MET
Phenylpiracetam
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Experience:BK-2C-B - Various experiences
5-MeO-DALT
Coluracetam
25N-NBOMe
4-FA
Experience:800 seeds LSA - My First Trip Ever
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
THJ-018
DOM
Aniracetam
PRO-LAD
Memantine
Ibogaine
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
Experience:40mg - Brothermind and the Forest's Hand
5F-PB-22
Methallylescaline
1P-ETH-LAD
1B-LSD
JWH-073
Proscaline
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
2C-T-21
Experience:2 tabs DOB - My DOB Nightmare
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Oxiracetam
Allylescaline
DET
3-MeO-PCE
Psilocybin mushrooms
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
5-MeO-DiPT
DOC
5-MeO-MiPT
5-Hydroxytryptophan
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Experience:3g mimosa / 3g syrian rue - Connecting with my body
4-AcO-DiPT
TMA-6
Pregabalin
AL-LAD
DMT
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
THJ-2201
2C-D
Selective serotonin reuptake inhibitor
25I-NBOMe
Experience:120mg - Garden of The Gods
4-HO-DiPT
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
25C-NBOMe
4-HO-EPT
2C-C
PARGY-LAD
Βk-2C-B
Chameleon.jpgChameleon by Anonymous.
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Experience:1000 Morning Glory seeds - Rediscovering the Self
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Experience:4x 200ug tabs - You do not need to understand
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
5-MeO-DiBF
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
MiPT
25C-NBOH
Bufotenin
2C-T-7
TMA-2
MiPLA
Piracetam
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
4-AcO-MiPT
25B-NBOH
4-HO-MET
Experience:4-HO-MiPT / A care free psychedelic getaway
MDEA
MDAI
Experience:4.5g - The Grand Introduction to Beauty and Fear
2C-P
DOB
LSD
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Mescaline
2C-T-2
Cannabis
ETH-LAD
GABAergic hallucinogens
Omberacetam
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Paradise island by Xanny.jpgParadise island by Subsentience
Ayahuasca
6-APDB
4-AcO-DET
DOI
Experience:1mg 25c-NBOMe - Experiment in my room
2C-B
ALD-52
4-AcO-MET
25B-NBOMe
4-AcO-DMT
LSZ
6-APB
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
MPT
DiPT
Experience:337mg DMT fumarate - A Day With DMT
4-HO-MPT
2C-H
EPT

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.